This is a pre-announced, fully expected final tranche — no new information or surprise. Monitor GSK's Q2 2026 earnings for any update on future capital return plans or changes to the buyback authorization. The stock is unlikely to react to this filing alone.
Price Chart
Executive Summary
GSK announced the fifth and final tranche of its £2 billion share buyback programme, with up to approximately £0.18 billion to be repurchased through Citigroup Global Markets Limited starting May 11, 2026, and expected to complete by June 26, 2026. This is a routine capital return execution — the programme was pre-announced in February 2025 and this filing merely confirms the final tranche mechanics.
Key Facts
- Final tranche of up to approximately £0.18 billion (about $0.23 billion) of the previously announced £2 billion buyback programme.
- Purchases expected to commence on May 11, 2026 and complete by June 26, 2026.
- To date, GSK has repurchased 114,436,378 ordinary shares for aggregate consideration of approximately £1.82 billion.
- Buyback executed through non-discretionary agreement with Citigroup Global Markets Limited on London Stock Exchange and Cboe Europe.
- No repurchases will be made in the United States or in respect of GSK's American Depositary Receipts.
Financial Impact
Up to approximately £0.18 billion in share repurchases over ~6 weeks, completing the £2 billion programme.
Risk Factors
- Buyback execution may be paused or adjusted if market conditions deteriorate or regulatory parameters change.
- No incremental signal about underlying business performance — capital return does not offset fundamental risks.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001654954-26-004643 |
| Document: 0001654954-26-004643-index-headers.html | 0001654954-26-004643 |
| Document: 0001654954-26-004643-index.html | 0001654954-26-004643 |
| Document: 0001654954-26-004643.txt | 0001654954-26-004643 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 10, 2026 19w ago | 6-K | $25.12 $25.25 | ▲ +0.52% | ▼ −1.62% | $26.12 (+3.98%) |
Jun 9, 2026 20w ago | 6-K | $24.66 $25.50 | ▲ +3.41% | ▲ +1.60% | $26.12 (+5.92%) |
Jun 9, 2026 20w ago | 6-K | $24.66 $25.50 | ▲ +3.41% | ▲ +1.60% | $26.12 (+5.92%) |
Jun 1, 2026 21w ago | 6-K | $24.25 $24.66 | ▲ +1.69% | ▲ +4.44% | $26.12 (+7.71%) |
Jun 1, 2026 21w ago | 6-K | $24.25 $24.66 | ▲ +1.69% | ▲ +4.44% | $26.12 (+7.71%) |
May 28, 2026 21w ago | 6-K | $24.58 $24.66 | ▲ +0.33% | ▲ +0.01% | $26.12 (+6.27%) |
May 27, 2026 21w ago | 6-K | $25.57 $23.94 | ▼ −6.37% | ▼ −7.58% | $26.12 (+2.15%) |
May 26, 2026 22w ago | 6-K | $25.50 $24.25 | ▼ −4.90% | ▼ −5.99% | $26.12 (+2.43%) |
May 26, 2026 22w ago | 6-K | $25.50 $24.25 | ▼ −4.90% | ▼ −5.99% | $26.12 (+2.43%) |
May 22, 2026 22w ago | 6-K | $26.00 $24.25 | ▼ −6.73% | ▼ −8.39% | $26.12 (+0.46%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers